SPONSORED CONTENT
As 340B covered entities continue to feel the financial impact of Medicare Part B reimbursement cuts and drug manufacturer actions that limit access to 340B pricing, a new Administration and new Congress will soon be in place. What will this mean for the future of the 340B program?
Join Omnicell for a live virtual event, “View from Capitol Hill: An Inside Look at the Latest Developments Shaping the 340B Program,” to hear from multiple 340B stakeholders in a lively
SPONSORED CONTENT by Jim Jorgenson, CEO, Visante
2020 was a year like no other! Dominated by challenges and uncertainty with the pandemic and the economy, and the political landscape overshadowing everything.
As always, and particularly in the face of rising challenges, we would like to thank our many clients for trusting us to support their organizations and to help them weather the storm as we head into what will hopefully be a better 2021.
As we look ahead, as
…*Sign up for news summaries and alerts from 340B Report
